Life Sciences/Animal Health and Research
Q: One of the emerging treatments at KU Cancer Center has been the CAR T-cell program. What does the future of the program look like at KU and what does this particular treatment look like for solid mass tumors and…
more
A quick-turnaround, at-home COVID-19 test may soon be available due to the ongoing work of researchers at the University of Kansas. Made possible through funding provided by the National Institutes of Health, several bioengineering and chemistry graduate students are working…
more
A new study has begun at the University of Kansas Medical Center as it started clinical trials for a new COVID-19 treatment Tuesday. The new treatment aims to help infected individuals with mild COVID-19 symptoms that have not been hospitalized…
more
Time for some Ingram’s 250 math: What’s i250 x 5? If you came up with 1,250, hats off to your grade-school math teachers—their lessons clearly took hold. But with this being the fifth year of our recognition of the 250…
more
Last week a large, international AstraZeneca COVID-19 vaccine trial was halted due to reports of a strong adverse effect in a participant, thought to be due to the vaccine. This week, the vaccine trial has resumed in the U.K., though…
more
AP – Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot. In a statement issued Tuesday evening, the company said its,…
more
One Kansas City metro facility has been hard at work processing COVID-19 samples, working with a different kind of sampling process that collects saliva rather than swabs. Lenexa-based Clinical Reference Laboratory has been testing around 6,000 saliva samples every day,…
more
In an announcement made by Kansas Gov. Laura Kelly on Friday, the Thermo Fisher Scientific in Lenexa has opened a new site will help increase the amount of statewide testing. Named the Viral Transport Media manufacturing site, the additional facility…
more
COLUMBIA, Mo. (AP) — A Washington University saliva test for the coronavirus has been approved by the Food and Drug Administration (FDA), Missouri Gov. Mike Parson announced Wednesday. The St. Louis-area university worked with biotechnology company Fluidigm to develop the…
more
Plans for a large-scale trial to be conducted with Pfizer and BioNTech’s first vaccine (referred to as B1) were soon altered, the companies instead conducting the trial using a second vaccine, called B2. On July 1, the companies presented data…
more